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Abstract
Eating disorders and schizophrenia are both moderately to highly heritable and share significant genetic risk despite distinct 
diagnostic criteria. Large-scale family studies on the co-aggregation of these disorders are lacking. Thus, we aimed to 
estimate the co-occurrence and familial co-aggregation of these disorders within the entire Swedish and Danish population. 
The proband cohort consisted of individuals born in Sweden (1977–2003) and Denmark (1984–2006) and still residing in 
their respective country at age six (NSweden = 2,535,191, NDenmark = 1,382,367). Probands were linked to their biological 
parents, siblings, grandparents, uncles/aunts, and cousins. Diagnoses for anorexia nervosa (AN) and other eating disorders 
(OED: bulimia nervosa, binge-eating disorder, and eating disorder not otherwise specified) for probands and schizophrenia 
diagnoses for both probands and relatives were obtained. The likelihood of having schizophrenia in those with AN or OED 
and their relatives was compared with individuals without eating disorder diagnoses and their relatives. Probands with AN or 
OED were more likely to have schizophrenia than probands without these disorders. All relatives of probands with AN or 
OED (except parents and uncles/aunts of probands with AN) were at increased risk of schizophrenia. In general, the 
magnitude of odds ratios attenuated with decreasing genetic relatedness. These results suggest familial liability contributes 
to the association between eating disorders and schizophrenia. Clinicians should be mindful of this comorbid and 
co-aggregation pattern as it may influence case conceptualization and treatment decisions.
Introduction
Schizophrenia is a severe psychiatric disorder characterized
by disordered thoughts, perceptions, and behaviors with
onset typically in late adolescence and early adulthood,
affecting about 21 million people worldwide [1, 2]. Eating
disorders, including anorexia nervosa (AN), bulimia ner-
vosa, and binge-eating disorder, are also serious disorders
usually arising in adolescence and early adulthood. Both
schizophrenia and eating disorders are associated with
considerable somatic and psychiatric morbidity, as well as
elevated mortality rates [3–5].
Schizophrenia and eating disorders are highly heritable
conditions with twin-based heritability estimates of 64–81%
for schizophrenia and 50–83% for eating disorders [6–9].
Despite the distinct diagnostic criteria of these disorders,
significant positive single-nucleotide polymorphism-based
genetic correlations between schizophrenia and AN have
been reported in previous studies (rg= 0.19–0.29) [10, 11].
Although a small literature explores comorbidity between
eating disorders and schizophrenia [12–15], almost no
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research has been conducted examining the co-occurrence
of schizophrenia and eating disorder diagnoses within
individuals and co-aggregation of these disorders in families
using population-based data.
However, relationships between symptoms of eating
disorders and schizophrenia have been explored in a few
epidemiological investigations. Eating disturbances (e.g.,
pica, faddiness, refusal) in childhood were found to be asso-
ciated with schizophrenia in adulthood in a small case-control
study [16]. Psychotic experiences during early adolescence
were associated with increased risk for disordered eating
behaviors such as binge eating, purging, and fasting
in late adolescence in a UK birth cohort [17]. Moreover,
an association between having a first-degree relative with
schizophrenia and the lifetime risk for bulimia nervosa was
reported in the National Survey of American Life [18].
However, since these results were primarily based on small
clinical samples or self-reported data, it remains unclear if the
co-occurrence of clinically diagnosed eating disorders and
schizophrenia, as well as the familial co-aggregation of these
disorders is present at the population level.
The genetic association between schizophrenia and eating
disorders other than AN is still unknown, and whether these
disorders have common familial risk is unclear. Comparing
co-aggregation of disorders across different types of relatives
can provide information on the extent to which the degree of
relatedness influences the risk of schizophrenia. Accordingly,
additional investigation into the nature and impact of the
shared genetic etiology between schizophrenia and eating
disorders is merited.
The primary aim of this study was to estimate the
co-occurrence and familial co-aggregation between schizo-
phrenia and eating disorders in the Swedish and Danish
populations.
Materials and methods
The study has been approved by the Regional Ethics
Review Board in Stockholm, Sweden (Dnr 2013/862–31/5)
and the Health Data Protection Agency in Denmark
(FSEID00000098). The study used population-based reg-
isters, and no individuals in the study populations were
identifiable at any time.
Data sources
Sweden: unique personal identification numbers were used
to link several Swedish registers. We obtained sex and birth
year information from the Swedish Total Population Reg-
ister [19]. Information regarding stillbirths and congenital
malformations was acquired from the Swedish Medical
Birth Register [20]. Dates and causes of death, when
applicable, were obtained from the Swedish Cause of Death
Register (CDR). We received immigration and emigration
data via the Swedish Migration Register. Using the Swedish
Multi-Generation Register [19], we linked individuals
(probands) to their biological parents and other relatives.
Records of psychiatric inpatient (since 1973) and outpatient
(since 2001) contacts from across Sweden were obtained
from the Swedish National Patient Register (NPR, based on
the International Classification of Diseases (ICD)) [21]. We
also derived eating disorder diagnoses from two other
Swedish National Quality Registers [Riksät and Stepwise,
based on the Diagnostic and Statistical Manual of Mental
Disorders, 4th Edition, Text Revision, DSM-IV-TR [22]]
[23]. Death due to eating disorders or schizophrenia
obtained from the Swedish CDR also constituted diagnoses.
Denmark: we obtained sex, birth year, information on
parental IDs, and continuously updated information on places
of residence and vital status from the Danish Civil Regis-
tration System (CRS) [24]. Relatives were identified through
CRS. Unique personal identification numbers were used to
link all Danish national registers. Congenital malformation
information was acquired from the Danish Medical Birth
Register [25]. Adoptive information came from Statistics
Denmark [26]. Records of all admissions to Danish psy-
chiatric inpatient facilities (since 1970) were taken from the
Danish Psychiatric Central Research Register (PCRR, based
on ICD) [27]. We also obtained diagnostic records on all
inpatient (since 1977) and outpatient (since 1995) admissions
to public hospitals from the Danish NPR [28]. Death due to
eating disorders or schizophrenia as recorded in the Danish
CDR also constituted diagnoses.
Study population
The Swedish proband cohort included individuals born
between January 1, 1977 and December 31, 2003 (3,469,851
individuals) with the following exclusions: stillbirths and
congenital malformations (n= 105,642), death before 6th
birthday (n= 12,988), emigration before 6th birthday (n=
82,229), birth outside of Sweden/immigration (n= 708,335),
no parental information (n= 20,733), and adopted children
(n= 4733), yielding a final sample of 2,535,191 individuals.
We followed the study population until December 31, 2013,
when the youngest individuals were 10 years old and the
oldest individuals were 36.
The Danish proband cohort included individuals born
between January 1, 1984 and December 31, 2006
(1,945,191 individuals) with the following exclusions:
congenital malformations (n= 47,924), death prior to 6th
birthday (n= 10,196), emigration prior to 6th birthday (n=
25,414), disappearance prior to 6th birthday (n= 694), birth
outside of Denmark/immigration (n= 462,057), no parental
information (n= 11,203), and adopted children (n= 5336),
yielding a final sample of 1,382,367 individuals. We fol-
lowed the study population until December 31, 2016, when
the youngest individuals were 10 years old and the oldest
individuals were 32.
Finally, using the Swedish Multi-Generation Register
and Danish CRS, we identified six cohorts of biological
relatives representing decreasing levels of shared genetic
and environmental relatedness: parents, full siblings
(excluding monozygotic twins in Sweden and excluding
all twins in Denmark as zygosity was not available in the
registers to which we had access), grandparents, half sib-
lings, uncles/aunts (full siblings of probands’ biological
parents), full cousins (biological children of defined
uncles/aunts). For all of the relatives related to the pro-
bands, individuals born before January 1, 2008 in Sweden
and born before January 1, 2011 in Denmark were inclu-
ded. All aforementioned relatives (except grandparents)
without parental information were excluded. Immigrants
as well as individuals who emigrated or died before their
6th birthday were excluded.
Study variables—eating disorders
Sweden: we defined and analyzed eating disorders grouped
in two ways based on lifetime diagnoses of eating disorders
in the Swedish NPR, the quality registers, and CDR before
December 31, 2013: (1) AN, defined as any diagnosis of AN
or atypical AN, identified with a Swedish ICD-9 code 307B
and ICD-10 codes F50.0 or F50.1 in the NPR, or meeting
DSM-IV-TR criteria for AN (307.1) or atypical AN (307.50,
criteria 1 and 2) in the quality registers (other lifetime eating
disorders could be present); (2) other eating disorder (OED),
defined as having any eating disorder other than AN, iden-
tified with ICD-9 codes 307F and ICD-10 codes F50.2,
F50.3, or F50.9 in the NPR, or meeting DSM-IV-TR criteria
for any eating disorders other than AN (bulimia nervosa
(307.51), atypical bulimia nervosa (307.50, criteria 3), or
eating disorders not otherwise specified) in the quality reg-
isters. Both AN and OED were recorded if an individual
received both diagnoses.
Denmark: probands were classified with AN (ICD-10:
F50.0 or F50.1), or OED (ICD-10: F50.2, F50.3, F50.8, or
F50.9) from the Danish NPR, PCRR, and CDR if they have
at least one occurrence of an in- or outpatient eating dis-
order contact in PCRR or NPR or a registration of eating
disorder as a cause of death in CDR, before January 1,
2017. Both AN and OED were recorded if an individual
received both diagnoses.
Study variables—schizophrenia
Sweden: similar to previous studies [8, 29], we defined
schizophrenia as ≥2 inpatient or outpatient treatment
contacts for schizophrenia or schizoaffective disorders
from the Swedish NPR and the CDR, identified with
ICD-8 codes 295.0–295.9 (except 295.5), Swedish ICD-9
codes 295A–295H (except 295F), 295W, 295X, V11A,
and ICD-10 codes F200–F209 (except F207), F231, F232,
F250–F252, F258, F259.
Denmark: we identified individuals with schizophrenia
from the Danish PCRR, NPR, and CDR, with ≥2 records of
ICD-8 codes 295.0–295.9 (except 295.5), ICD-10 codes
F20.0–F20.9 (except F20.7), F23.1, F23.2, F25.0–F25.2,
F25.8, F25.9.
Statistical analysis
Co-occurrence of eating disorders and schizophrenia within
probands
To evaluate the association between eating disorders
(independent variable) and schizophrenia (dependent vari-
able), logistic regressions were performed in the full pro-
band cohort for each eating disorder subgroup, adjusted for
sex and birth year (in quartiles), to obtain odds ratios (ORs)
with 95% CIs in both countries separately. Sex stratified
analyses were performed as well.
Familial co-aggregation of eating disorders and
schizophrenia
We fit a logistic regression model for each of the six relative
cohorts to evaluate the familial co-aggregation patterns of
eating disorders (independent variable, from probands) and
schizophrenia (dependent variable, from relatives) by esti-
mating the ORs of schizophrenia in relatives of individuals
(probands) with eating disorders compared with the same
type of relatives of individuals (probands) without eating
disorders. A higher OR in relatives with closer relatedness
compared with more distant relatives suggests that eating
disorders and schizophrenia share genetic and/or family
environmental liabilities.
Because sex differences in the association between
schizophrenia and eating disorders were not the main focus
of this study, we combined males and females and adjusted
for sex to increase the power in the analyses of familial co-
aggregation. In each model, we adjusted for birth year (in
quartiles) and sex for both the proband and their relatives.
For all analyses, we used a cluster–robust (sandwich)
estimator for standard error calculation, where clusters were
identified via family identification numbers, which linked
relatives to control for intrafamilial correlation within the
data. Data management was performed using SAS, version
9.4 (SAS Institute, Inc.) in Sweden and Stata, version 15 in
Denmark; analyses were performed using R, version 3.4.3
in Sweden and Stata, version 15 in Denmark.
Sensitivity analyses
First, we repeated the analysis in the full sibling cohort with
sex stratification. Next, we conducted tests to assess familial
factors. In the full sibling cohorts, we repeated the analyses
with additional adjustment for eating disorders in the full
siblings (the person from whom we acquired information on
schizophrenia status). ORs that remain in the same direction
and significant further support the contribution of shared
familial risk factors to eating disorders and schizophrenia
(e.g., [30], explained in Supplementary method with Sup-
plementary Figs. 1 and 2). Finally, since it is not uncommon
for individuals to present with different eating disorder
diagnoses across the course of their illness [31], we also
performed the analysis with a stricter eating disorder cate-
gory definition by evaluating individuals (probands) with
exclusively AN or OED diagnoses (i.e., no indication of




Sweden: a total of 2,535,191 probands born 1977–2003
in Sweden were followed from their 6th birthday to
December 31, 2013. During the observation period,
12,863 (0.51%) probands received at least one diagnosis
of AN, and 21,454 (0.85%) probands received at least one
diagnosis of OED. We identified 3146 (0.12%) probands
with schizophrenia.
Denmark: a total of 1,382,367 probands born 1984–2006
in Denmark were followed from their 6th birthday to
December 31, 2016. During the observation period, 7120
(0.52%) probands received at least one diagnosis of AN,
and 9731 (0.70%) probands received at least one diagnosis
of OED. We identified 6224 (0.45%) probands with
schizophrenia.
Females were more likely to receive eating disorder
diagnoses, whereas the prevalence of schizophrenia was not
significantly different between males and females in either
country. The distribution of schizophrenia stratified by sex
and eating disorder diagnosis among probands is shown
in Table 1. Information about the relatives is detailed in
Table 2.
Co-occurrence of eating disorders and schizophrenia
within probands
Table 3 shows the ORs of schizophrenia for each eating
disorder category and stratified by sex in the Swedish and
Danish proband population. Individuals with AN had an
increased risk of schizophrenia, reported as OR [95% CI]:
Table 1 Sample sizes (N) and prevalence (%) of the proband population in Sweden and Denmark.
Anorexia nervosa (AN) Other eating disorders (OED)
Yes No Yes No
Sweden Denmark Sweden Denmark Sweden Denmark Sweden Denmark
Eating disorders
No. of probands 12,863 7120 2,522,328 1,375,247 21,454 9731 2,513,737 1,372,636
Female 12,121 6599 1,225,367 668,121 20,122 8672 1,217,366 666,048
Male 742 521 1,296,961 707,126 1332 1059 1,296,371 706,588
Prevalence, % 0.51 0.52 NA NA 0.85 0.70 NA NA
Female 0.98 0.98 NA NA 1.63 1.29 NA NA
Male 0.06 0.07 NA NA 0.10 0.15 NA NA
Schizophrenia
No. of probands (%) 72 (0.56) 226 (3.17) 3074 (0.12) 5998 (0.44) 135 (0.63) 362 (3.72) 3011 (0.12) 5862 (0.43)
Female 62 (0.51) 210 (3.18) 1129 (0.09) 2774 (0.42) 113 (0.56) 329 (3.79) 1078 (0.09) 2655 (0.40)
Male 10 (1.53) 16 (3.07) 1945 (0.15) 3224 (0.46) 22 (1.65) 33 (3.12) 1933 (0.15) 3207 (0.45)
Sweden Denmark




aThe prevalence of schizophrenia is the overall prevalence among proband population in Sweden and Denmark without stratification by eating
disorder subgroup.
5.66 [4.46, 7.19] in Sweden and 6.17 [5.38, 7.08] in
Denmark. The risk for schizophrenia in individuals with
OED was also significantly increased (6.15 [5.14, 7.36] in
Sweden and 7.17 [6.41, 8.01] in Denmark). We also
examined the temporal diagnostic relationships between
the first diagnoses for AN/OED and schizophrenia in our
dataset: among individuals with both AN and schizo-
phrenia, 80% in Sweden and 81% in Denmark of those
received an AN diagnosis earlier than schizophrenia;
among those with both OED and schizophrenia, 70% in
Sweden and 74% in Denmark received an OED diagnosis
prior to schizophrenia.
There was no statistically significant difference between
ORs for schizophrenia in individuals with OED and
individuals with AN in either country (the OR for AN was
included in the 95% CI of OED and vice versa). Males
with AN or OED had a significantly higher risk for schi-
zophrenia than females in Sweden (P valueAN= 0.035,
P valueOED < 0.001). However, this was not the case in the
Danish sample.
Familial co-aggregation of eating disorders and
schizophrenia
Figure 1 presents the ORs for schizophrenia in individuals
(probands) with AN and their relatives compared with
individuals (probands) without AN and their relatives. Full
siblings of probands with AN were at increased risk of
schizophrenia (OR [95% CI]: 1.66 [1.21, 2.27] in Sweden
and 1.47 [1.13, 1.92] in Denmark) compared with full
siblings of probands without AN. Half siblings (including
maternal and paternal half siblings) of probands with
AN had an increased risk for schizophrenia in Denmark
(1.42 [1.07, 1.87]), but the effect was not statistically
significant in Sweden (1.33 [0.90, 1.95]). Grandparents
of probands with AN had higher risk for schizophrenia
(1.22 [1.02, 1.46]) in Sweden. However, this was not seen
in Denmark (0.91 [0.69, 1.21]). No significant association
was observed in other relatives (parents, uncles/aunts, and
cousins). Overall, the magnitude of ORs attenuated with
decreasing genetic relatedness among the youngest gen-
eration (full sibling > half sibling > cousin).
All relatives of probands with OED were at increased
risk of schizophrenia; however, the effects among half
siblings and uncles/aunts were not statistically significant in
the Danish sample (Fig. 2). Overall, the magnitude of ORs
attenuated with decreasing genetic relatedness. We also
found a significant increase in the ORs for schizophrenia in
Table 2 Sample sizes and prevalence of schizophrenia of the relatives in Sweden and Denmark.
Characteristics Parent Full sibling Grandparent Half sibling Aunt/uncle Cousin
Unique relativesa, n
Sweden 2,329,145 2,295,669 2,665,509 781,056 2,467,766 3,166,256
Denmark 1,363,092 1,218,780 1,469,031 410,966 1,221,060 1,415,327
Schizophreniac, n
Sweden (%) 5482 (0.24) 3017 (0.13) 6877 (0.26) 2083 (0.27) 14,940 (0.61) 6394 (0.20)
Denmark (%) 4446 (0.33) 5070 (0.42) 4125 (0.28) 3383 (0.82) 9774 (0.80) 6170 (0.44)
Analytical relative pairsb, n
Sweden 4,367,376 3,369,781 8,265,606 1,432,934 7,259,332 13,905,022
Denmark 2,450,181 1,703,887 4,454,458 703,569 3,427,089 6,052,414
aUnique relatives, n is the number of unique individuals in each relative cohort.
bAnalytical relative pairs, n is the number of relative-index (SCZ outcome–ED exposure) pairs in analysis. Index person A with relative person B
could also be analyzed as index person B with relative A if they fulfilled the requirement for each cohort.
cSchizophrenia, n is the number of unique individuals with schizophrenia in each relative cohort, and the percentage in parentheses is the
prevalence of schizophrenia for each relative type.
Table 3 ORs for schizophrenia in probands with eating disorders.





5.66 (4.46, 7.19) 6.17 (5.38, 7.08)
Female 5.17 (4.00, 6.68) 6.18 (5.36, 7.13)




6.15 (5.14, 7.36) 7.17 (6.41, 8.01)
Female 5.47 (4.50, 6.64) 7.22 (6.42, 8.12)
Male 13.21 (8.62, 20.26) 8.05 (5.66, 11.46)
The table shows ORs with 95% CI for schizophrenia in individuals
with eating disorders compared with individuals without eating
disorders.
OR odds ratio, 95% CI 95% confidence interval, AN anorexia nervosa,
OED other eating disorders (non-AN eating disorders).
parents of probands with OED compared with those for
parents of probands with AN (Supplementary Table 1).
Sensitivity analyses
The results for sex-specific analyses of familial co-
aggregation in full siblings are shown in Supplementary
Table 2. In full siblings, males who had a sister with AN/OED
had 1.5 times higher odds of schizophrenia compared with
males who had a sister without AN/OED in both Sweden and
Denmark. The results for other combinations were incon-
sistent between countries.
The results for analyses of full siblings with additional
adjustment of AN/OED in the outcome person are shown in
Supplementary Table 3. ORs for schizophrenia in full sib-
lings of probands with eating disorders remained statisti-
cally significantly higher than 1 even after adjusting for the
full siblings’ eating disorders, supporting that familial fac-
tors partly contribute to the observed co-aggregation within
relatives (explained in Supplementary method).
The results of analyses with a restricted eating disorder
category definition are shown in Supplementary Table 4.
These results are largely similar to the primary findings.
Discussion
We conducted a study of schizophrenia and eating disorder
co-occurrence in a population of over 2.5 million probands
in Sweden and 1.3 million probands in Denmark. This is the
only known study exploring familial co-aggregation of
schizophrenia and eating disorders. Our results demonstrate
that individuals with any type of eating disorder had 6–7
times higher odds of schizophrenia than individuals without
eating disorders. The pattern of familial co-aggregation of
schizophrenia and eating disorders across different relative
types stratified by AN and OED indicated different
mechanisms for shared factors in schizophrenia and AN vs.
schizophrenia and OED.
A positive genetic correlation between schizophrenia and
AN has been found in previous studies [10, 11], which is in
line with our findings of elevated risk of schizophrenia in
probands with AN, indicating that genetic factors contribute
to the co-occurrence of AN and schizophrenia. However,
the observed association of AN and schizophrenia in pro-
bands and full siblings (and likely half siblings) but not
parents is difficult to interpret. One potential explanation
could be the low fecundity observed in schizophrenia [32].
Fig. 1 OR for SCZ in individuals with AN and their relatives,
compared with individuals without AN and their relatives. The
forest plot shows ORs with 95% CI for SCZ in individuals with AN
and their relatives compared with individuals without AN and their
relatives in Sweden and Denmark. OR odds ratio, 95% CI 95% con-
fidence interval, SCZ schizophrenia, AN anorexia nervosa.
Fig. 2 OR for SCZ in individuals with OED and their relatives,
compared with individuals without OED and their relatives. The
forest plot shows ORs with 95% CI for SCZ in individuals with OED
and their relatives compared with individuals without OED and their
relatives in Sweden and Denmark. OR odds ratio, 95% CI 95%
confidence interval, SCZ schizophrenia, OED other eating disorders
(non-AN eating disorders).
Since we expanded our cohorts from probands to their par-
ents, individuals with schizophrenia without children would
not be represented in the study population, which might lead
to the lack of observed association between probands with
AN and parents with schizophrenia. However, the association
between this type of pair (probands–parents) in schizophrenia
and OED has been detected, which indicates that the low
fecundity for schizophrenia was not the only factor. Shared
childhood environmental effects could also account for some
of the association. Although shared environmental factors do
not contribute to liability to AN based on a previous twin
study [33], they do comprise 11% of the liability to schizo-
phrenia [9]. Another potential explanation could be de novo
mutations, which increase with paternal age and have been
associated with increased risk for both schizophrenia and AN
[34, 35]. In that case, the association would diminish in
full siblings after adjusting for paternal age. However, we did
not observe a significant change in the adjusted model
(Supplementary Table 5).
For added context, we also tested in our full sibling
cohort for the risk of other psychiatric disorders (obsessive-
compulsive disorder, major depression, and anxiety dis-
orders), which have demonstrated positive genetic correla-
tions with AN in previous studies [11, 36]. Interestingly, the
magnitude of ORs for the other psychiatric disorders and
AN are largely consistent with the genetic correlation found
between them (Supplementary Table 6). Moreover, a recent
study revealed the pleiotropy effects of contributing loci
associated with eight different psychiatric disorders, iden-
tifying three groups of inter-related disorders [37]. Although
AN and schizophrenia still belong to different clusters, a
number of pleiotropic loci were found to be associated with
both disorders [37]. Together with results from Supple-
mentary Table 6, these findings indicate a broader domains
underlying genetic risk to psychopathology, which are
in conflict with the traditional categorical taxonomies of
mental disorders [38].
In terms of the association between schizophrenia and
OED, significant evidence for linkage to marker D10S1423
on 10p has been observed in both schizophrenia and buli-
mia nervosa [39, 40]. Furthermore, increased schizophrenia
polygenic risk scores have been found to be associated with
greater odds of having binge-eating behaviors [41]. Similar
to previous findings of association between having a first-
degree relative with schizophrenia and the lifetime risk for
bulimia nervosa from survey data [18], our results show
consistent association of the risk for schizophrenia in first-
degree relatives of probands with OED. By comparing ORs
across different types of relatives, our study provided dee-
per exploration of the origins of the familial co-aggregation.
If the familial co-aggregation was primarily due to genetic
factors, ORs would be expected to decrease based on the
degree of relatedness. We did observe a tendency for the
magnitude of ORs for schizophrenia associated with OED
to attenuate with decreasing genetic relatedness. This sug-
gests a common genetic contribution for schizophrenia and
OED, and supports the need for studies to further identify
the shared genetic factors.
Limitations of this study include under-detection of
individuals with schizophrenia or eating disorders diag-
nosis. Individuals might have an outpatient diagnosis
for which the records were only available after 2001 in
Sweden. Records from private caregivers also cannot be
completely captured in both countries. Since it is only
possible to follow individuals until the latest update of the
data, we cannot capture recent diagnoses or presentations
later in life. Under-detection would likely lead to under-
estimation of the effects. Nevertheless, if relatives of
people with a psychiatric diagnosis are more likely to have
healthcare exposures, they may have a greater chance of
receiving diagnoses compared with relatives of people
without a psychiatric diagnosis, which might lead to an
overestimation of the effect. Misdiagnosis is potentially a
concern if, for example, feeding behavior changes as a
result of psychotic symptoms and is incorrectly attributed
to an eating disorder. However, <1% of all cases in the
Swedish quality registers for eating disorders were later
determined to be erroneous, suggesting that this is unlikely
to impact our results [23]. On a related note, it is a lim-
itation of current clinical diagnostic systems that they only
permit separate diagnoses of schizophrenia and eating
disorders despite the fact that these may co-occur in
the same individual due to a singular disease process.
Additional research to resolve the origin of this putative
comorbidity is needed. Furthermore, the zygosity of twins
was not available in Danish databases to which we had
access. Consequently, we included dizygotic twins as full
siblings in Sweden, but not in Denmark. However, this did
not appear to have a strong influence on the final results. In
addition, since people with AN might later develop OED
or vice versa, we performed sensitivity analyses using
strict definitions of AN and OED. No appreciable differ-
ences emerged (Supplementary Table 4). Another potential
bias could be differing diagnostic practices by clinicians
for both eating disorders and schizophrenia in Sweden and
Denmark, which could increase heterogeneity. Previous
validation studies have however confirmed a low number
of false-positive diagnoses for schizophrenia [42–44]. We
also observed that the overall prevalence of schizophrenia
was higher in Denmark than in Sweden. Since the oldest
individuals in the Swedish proband cohort were 36 vs. 32
in Denmark, a higher proportion of probands should have
passed through the peak ages at of onset, driving the
prevalence in the opposite of the observed direction. We
were unable to identify the cause of this discrepancy, but
note that it has been reported previously [45].
The main strengths of our study are studying large-scale
population-based cohorts, the national coverage of all
available psychiatric contacts, large sample size for both
disorders, and relatively consistent findings in two coun-
tries, strengthening both reliability and generalizability.
Restricting to at least two records of schizophrenia for case
definition also reduced potential bias due to misclassifica-
tion and increased certainty of the diagnoses.
By studying two large population-based cohorts, we
found that individuals with AN or OED were more likely to
have schizophrenia than people without these eating dis-
orders. Shared risk factors exist between schizophrenia and
eating disorders, particularly OED. Additional studies such
as genome-wide association studies of bulimia nervosa and
binge-eating disorder and calculation of genetic correlations
between schizophrenia and bulimia/binge-eating disorder
are needed to distinguish the shared and specific genetic and
environmental risk factors for schizophrenia and eating
disorders. Clinicians should be mindful of comorbidity
between eating disorders and schizophrenia as it may
inform case conceptualization and treatment decisions. For
example, AN treatment with the antipsychotic olanzapine
[46] might have differential outcomes in individuals with
family histories of schizophrenia or high schizophrenia
genetic risk. Future studies will address how family history
and genetic risk for schizophrenia influence the clinical
course of eating disorders.
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